- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x PLP: PYRIDOXAL-5'-PHOSPHATE(Covalent)
- 6 x IAA: ({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID(Non-covalent)
IAA.2: 13 residues within 4Å:- Chain A: W.67, I.68, Q.71, Q.72, Y.75, R.193, R.309, R.310
- Chain B: V.40, K.41, D.42, V.45
- Ligands: IAA.3
13 PLIP interactions:9 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:W.67, A:W.67, A:Q.71, A:Q.71, A:Y.75, A:Y.75, B:V.40, B:V.45
- Water bridges: A:R.310
- Salt bridges: A:R.309, A:R.310
- Hydrogen bonds: B:D.42, B:D.42
IAA.3: 7 residues within 4Å:- Chain A: R.193, F.196, R.242, D.306, R.309
- Chain B: V.45
- Ligands: IAA.2
12 PLIP interactions:11 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:F.196, A:R.309, B:V.45
- Hydrogen bonds: A:R.242, A:R.242, A:D.306, A:R.309
- Water bridges: A:D.306
- pi-Stacking: A:F.196, A:F.196
- pi-Cation interactions: A:R.309, A:R.309
IAA.4: 8 residues within 4Å:- Chain A: N.282, F.285, E.382, E.572, A.610, G.612, Y.613, R.770
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.285, A:F.285, A:Y.613, A:Y.613
- Hydrogen bonds: A:N.282
- Water bridges: A:G.612
- pi-Stacking: A:F.285, A:Y.613
IAA.6: 13 residues within 4Å:- Chain A: V.40, K.41, D.42, V.45
- Chain B: W.67, I.68, Q.71, Q.72, Y.75, R.193, R.309, R.310
- Ligands: IAA.7
13 PLIP interactions:4 interactions with chain A, 9 interactions with chain B- Hydrophobic interactions: A:V.40, A:V.45, B:W.67, B:W.67, B:Q.71, B:Q.71, B:Y.75, B:Y.75
- Hydrogen bonds: A:D.42, A:D.42
- Water bridges: B:R.310
- Salt bridges: B:R.309, B:R.310
IAA.7: 7 residues within 4Å:- Chain A: V.45
- Chain B: R.193, F.196, R.242, D.306, R.309
- Ligands: IAA.6
11 PLIP interactions:1 interactions with chain A, 10 interactions with chain B- Hydrophobic interactions: A:V.45, B:F.196, B:R.309
- Hydrogen bonds: B:R.242, B:R.242, B:D.306, B:R.309
- pi-Stacking: B:F.196, B:F.196
- pi-Cation interactions: B:R.309, B:R.309
IAA.8: 8 residues within 4Å:- Chain B: N.282, F.285, E.382, E.572, A.610, G.612, Y.613, R.770
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:F.285, B:F.285, B:Y.613, B:Y.613
- Hydrogen bonds: B:N.282
- Water bridges: B:G.612
- pi-Stacking: B:F.285, B:Y.613
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kosmopoulou, M.N. et al., Indirubin-3'-Aminooxy-Acetate Inhibits Glycogen Phosphorylase by Binding at the Inhibitor and the Allosteric Site. Broad Specificities of the Two Sites. LETT.DRUG DES.DISCOVERY (2005)
- Release Date
- 2006-03-07
- Peptides
- Glycogen phosphorylase, muscle form: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
SMTL ID : 1z62.1
Indirubin-3'-aminooxy-acetate inhibits glycogen phosphorylase by binding at the inhibitor and the allosteric site. Broad specificities of the two sites
Glycogen phosphorylase, muscle form
Toggle Identical (AB)Related Entries With Identical Sequence
1axr.1 | 1c8l.1 | 1e1y.1 | 1gpy.1 | 1lwn.1 | 1lwo.1 | 1pyg.1 | 1uzu.1 | 1xc7.1 | 1xkx.1 | 1xl0.1 | 1xl0.2 | 1xl1.1 | 1xl1.2 | 2amv.1 | 2amv.2 | 2amv.3 | 2f3p.1 | 2f3q.1 | 2f3s.1 | 2f3u.1 | 2fet.1 | 2fet.2 | 2fet.3 | 2ff5.1 | 2ff5.2 | 2ff5.3 | 2g9q.1 | 2g9r.1 | 2g9u.1 more...less...2g9v.1 | 2gpa.1 | 2off.1 | 2qlm.1 | 2qln.1 | 2qn1.1 | 2qn2.1 | 2qn3.1 | 2qnb.1 | 2qrg.1 | 2qrh.1 | 2qrm.1 | 2qrp.1 | 2qrq.1 | 3amv.1 | 3bcr.1 | 3bcs.1 | 3bcu.1 | 3bd6.1 | 3bd7.1 | 3bd8.1 | 3bda.1 | 3cut.1 | 3cut.2 | 3cuu.1 | 3cuu.2 | 3cuv.1 | 3cuw.1 | 3cuw.2 | 3e3l.1 | 3e3l.2 | 3e3n.1 | 3e3n.2 | 3e3n.3 | 3e3n.4 | 3e3n.5 | 3e3n.6 | 3ebo.1 | 3ebp.1 | 3g2h.1 | 3g2h.2 | 3g2i.1 | 3g2i.2 | 3g2j.1 | 3g2j.2 | 3g2k.1 | 3g2k.2 | 3g2l.1 | 3g2l.2 | 3g2n.1 | 3g2n.2 | 3mqf.1 | 3mrt.1 | 3mrv.1 | 3mrx.1 | 3ms2.1 | 3ms4.1 | 3ms7.1 | 3msc.1 | 3mt7.1 | 3mt8.1 | 3mt9.1 | 3mta.1 | 3mtb.1 | 3mtd.1 | 3np7.1 | 3np9.1 | 3npa.1 | 3s0j.1 | 3sym.1 | 3syr.1 | 3t3d.1 | 3t3e.1 | 3t3g.1 | 3t3h.1 | 3t3i.1 | 5lrc.1 | 5lre.1 | 5lrf.1 | 5o50.1 | 6y5c.1 | 6y5o.1